Articles
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
Glytec announced it secured a $36 million growth investment led by Savitr Capital and Hayfin Capital Management. WHAT IT DOESGlytec 's Glucommander system analyzes patient data in real time to provide insulin dosing recommendations as well as historical, prospective and patient-specific data. The offering integrates with electronic medical records.
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
, an online therapy platform, announced multi-year partnerships with the WNBA's Las Vegas Aces, Dallas Wings and 2024 Champion New York Liberty. BetterHelp offers access to licensed psychologists, marriage and family therapists, clinical social workers and board-licensed professional counselors. The partnership aims to align BetterHelp with the three WNBA teams' mental health initiatives and to drive conversations about the importance of mental health awareness among athletes.
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
India-based ABM Respiratory Care (ABMRC), a medical technology company involved in airway clearance and ventilation, announced the close of its Series B financing round, raising $14.8 million, $2.8 million above the company's $12 million target. Peter Soderberg, ABMRC's chairman of the board and managing partner of Worthy Venture Resources, led the oversubscribed round with participation from Blue Wave Capital, alongside new and existing investors.
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
, an AI-enabled chart review company, announced it will receive a strategic investment from Intermountain Heath's investment arm, Intermountain Ventures, and Intermountain Health will become an innovation partner and early user of Layer Health's AI-powered chart-review platform. The two companies are engaged in a multi-year venture to deploy Layer Health's AI platform across multiple clinical registries, aiming to improve the scalability of clinical data abstraction.
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
Cancer research organization City of Hope has co-led a study to show that characterizing genetic material close to chromosomes predicts how mutated, cancer-causing genes reprogram DNA and alter the tumor microenvironment. City of Hope said the new brain cancer research provides foundational knowledge with the potential to enhance the practice of precision medicine, enabling oncologists to deliver more customized therapies to patients with cancer.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 35
- Tweets
- 101
- DMs Open
- No
Jersey angst |A new survey reveals that 30 percent of New Jerseyans are very concerned about losing their jobs as a result of the COVID-19 outbreak. Read about how Garden State residents are being impacted by the pandemic. https://t.co/OtATDgW2yv
Jersey influence | Catalent Inc. @CatalentPharma is collaborating with Janssen Pharmaceutical Cos. to accelerate the availability of manufacturing capacity, and prepare for large-scale commercial manufacturing for J&J lead vaccine candidate for COVID-19. https://t.co/oK6TlxlkuS
Expanded testing | There has been a lot of pressure to increase COVID-19 testing. CVS expanded its testing capabilities and will offer self-swab tests at their Minute Clinics in New Jersey. https://t.co/pKkFZs2vH5